Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways - Resistance to Targeted Anti-Cancer Therapeutics

Yosef Yarden (editor), Moshe Elkabets (editor)

Paperback (02 Feb 2019)

$184.29

In Stock

Add to basket

Includes delivery to the United States

10+ copies available online - Usually dispatched within 7 days

Other formats & editions

New: Hardback (10 Apr 2018) $188.50

Publisher's Synopsis

This volume comprehensively covers the multiplicity and diversity of mechanisms underlying patient resistance to currently approved anti-cancer drugs, including tyrosine kinase inhibitors and monoclonal antibodies, blockers of growth factor receptors and their downstream pathways, which play essential functions in cancer progression. Each chapter will cover a specific group of targets and the cognate drugs, along with molecular modes of innate and evolving resistance.

Book information

ISBN:	9783030098179
Publisher:	Springer International Publishing
Imprint:	Springer
Pub date:	02 Feb 2019
Language:	English
Number of pages:	242
Weight:	454g
Height:	235mm
Width:	155mm
Spine width:	14mm